Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07027267 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery
A NA study, sponsored by Spirair.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07027267 is a NA study that is active but no longer recruiting, run by Spirair. The registered enrollment target is 50 participants.
The verdict
NCT07027267, a NA study, is active but no longer recruiting, sponsored by Spirair.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery
Interventions
- DEVICE Implantation of Spirair device into the middle turbinates
- DEVICE TurbAlign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07027267
The ClinicalTrials.gov registry entry for NCT07027267 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spirair, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Implantation of Spirair device into the middle turbinates is the first listed.
NCT07027267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07027267 about?
NCT07027267 is a clinical study titled "Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery". A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery
What is the current status of trial NCT07027267?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-04. Estimated completion is 2026-07-31.
What interventions are being tested in trial NCT07027267?
The interventions under investigation include: Implantation of Spirair device into the middle turbinates (DEVICE), TurbAlign (DEVICE).
Who is sponsoring clinical trial NCT07027267?
This trial is sponsored by Spirair, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.